What is NDC 0054-0576?

0054-0576 is the product NDC for Deferiprone, Deferiprone 500 mg/1 tablet, coated, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Hikma Pharmaceuticals USA Inc., NDC labeler code 0054. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Deferiprone?

6 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Deferiprone NDC 0054-0576 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0054-0576Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00054-0576Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0054-0576-25	0005405762500054057625	100 TABLET, COATED in 1 BOTTLE (0054-0576-25)Marketed from Jun 3, 2021

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Deferiprone
Generic name (nonproprietary): deferiprone
Active ingredients: Deferiprone — 500 mg/1
Dosage form: Tablet, Coated
Route: Oral
Labeler: Hikma Pharmaceuticals USA Inc.NDC labeler code 0054
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213239
Marketing start: Jun 3, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Iron Chelating Activity (Mechanism)
Identifiers: Product ID 0054-0576_85bc2162-59ea-409a-94c2-0edef74922f5SPL ID 85bc2162-59ea-409a-94c2-0edef74922f5SPL set ID d7ea0a84-c328-4636-8cd6-ad75f2074b22RxCUI 389242UNII 2BTY8KH53LUPC 0300540576288, 0300540576257
Pharmacologic class: Iron Chelator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400054057625 followed by a unit qualifier and the quantity

Package 00054-0576-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 1, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Deferiprone tablets are indicated for the treatment of transfusional iron overload in adult patients with thalassemia syndromes when current chelation therapy is inadequate. Limitations of Use: • Safety and effectiveness have not been established for the treatment of transfusional iron overload in patients with myelodysplastic syndrome or in patients with Diamond Blackfan anemia. Pediatric use information is approved for Chiesi USA, Inc.’s FERRIPROX ® (deferiprone) tablets. However, due to Chiesi USA, Inc.’s marketing exclusivity rights, this drug product is not labeled with that information. Deferiprone tablets are an iron chelator indicated for the treatment of transfusional iron overload …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0054-0576

What is NDC 0054-0576?: 0054-0576 is the product NDC for Deferiprone, Deferiprone 500 mg/1 tablet, coated, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Deferiprone.
What is the active ingredient?: Deferiprone.
Who is the labeler?: Hikma Pharmaceuticals USA Inc., NDC labeler code 0054. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Deferiprone?: 6 other product NDCs are listed under this name. See all Deferiprone NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Deferiprone NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Deferiprone	Deferiprone 500 mg/1	TabletOral	AvKARE	73190-095	73190-0095-01
Deferiprone	Deferiprone 1000 mg/1	Tablet, CoatedOral	DR. REDDY'S LABORATORIES, INC.	75907-348	75907-0348-50
Deferiprone	Deferiprone 500 mg/1	Tablet, CoatedOral	DR. REDDY'S LABORATORIES, INC.	75907-349	75907-0349-01
Deferiprone	Deferiprone 500 mg/1	TabletOral	Sun Pharmaceutical Industries, Inc.	51672-4196	51672-4196-01
Deferiprone	Deferiprone 1000 mg/1	TabletOral	Sun Pharmaceutical Industries, Inc.	51672-4237	51672-4237-04
Deferiprone	Deferiprone 1000 mg/1	Tablet, CoatedOral	Hikma Pharmaceuticals USA Inc.	0054-0711	00054-0711-1900054-0711-2300054-0711-28

Other NDCs under ANDA 213239

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213239
Product	Strength	Form · route	Labeler	Product NDC
Deferiprone	Deferiprone 1000 mg/1	Tablet, CoatedOral	Hikma Pharmaceuticals USA Inc.	0054-0711